How "Brexit" might affect the pharmaceutical industry.

@article{Gulland2016HowM,
  title={How "Brexit" might affect the pharmaceutical industry.},
  author={A. D. Gulland},
  journal={BMJ},
  year={2016},
  volume={353},
  pages={i2615}
}
This depends how the UK negotiates its exit from the EU. The UK could become part of the European Economic Area, like Norway, Liechtenstein, and Iceland. These countries are covered by the European Medicines Agency and still have access to the single marketing authorisation, meaning that companies only have to go through one approval process before launching their drugs throughout Europe. However, they have no influence over the operations of the EMA, unlike EU member states. If the… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…